AFPE Funds 68 Pharmaceutical Science Education Awards at 26 Pharmacy Schools

July 12, 2010 - Rockville, MD - The American Foundation for Pharmaceutical Education (AFPE) has awarded pharmaceutical science education awards totaling $476,500 to sixty-six PhD pharmaceutical science PhD degree students, and two pharmacy college faculty researchers at twenty-six schools & colleges of pharmacy for the upcoming 2010-2011 academic year.

The AFPE mission is to support pharmaceutical education in the United States by identifying and supporting the most talented future pharmaceutical scientists and pharmaceutical science college teachers. AFPE relies on annual tax-deductible contributions from pharmacy and pharmaceutical science companies, foundations, associations, alumni, and friends to fund the prestigious AFPE pharmaceutical education awards program. The sixty-eight awards fall into the following categories:

o 3 First Year Graduate School Fellowships awarded, in cooperation with the Kappa Epsilon, Phi Lambda Sigma, and Rho Chi pharmacy fraternities, to graduating PharmD degree students who have enrolled full-time in a pharmaceutical science PhD degree program at a school/college of pharmacy.

o 59 Pre-Doctoral Fellowships in Pharmaceutical Science to help advanced pharmaceutical science PhD degree candidates at schools and colleges of pharmacy complete the research and dissertation phase of their PhD degree program and begin careers as industry scientists, faculty teachers & researchers, and government agency scientists.

o 4 Pre-Doctoral Fellowships in Clinical Pharmaceutical Science to help advanced clinical pharmaceutical science PhD degree candidates at schools & college of pharmacy complete the research and dissertation phase of their PhD degree program and begin careers as industry scientists, faculty teachers & researchers, and government agency scientists.

o 2 Pharmacy College Faculty Development Fellowships to support pharmacy faculty teachers as they participate full-time in a 6-month research project in either community pharmacy practice or geriatric pharmacy.

The research projects of these 2010 AFPE award winners will address the following disease conditions and/or topics: adherence, age related diseases, AIDS/HIV, alcoholism, Alzheimer’s Disease, burns, cardiovascular disease, community pharmacy practice, Crohn’s Disease, Cystic Fibrosis, depression, diabetes, drug delivery, drug discovery, drug resistant microorganisms, epilepsy, geriatric disease management, geriatric pharmacy, hematology, medication therapy management (MTM), meningitis, nephrology, neuropsychiatric disease, obesity, oncology, Parkinson’s Disease, pediatrics, periodontal diseases, and pulmonary drug delivery

Note: The names, research titles, and academic institutions of the sixty-eight 2010 AFPE award winners are provided in the attached report: 2010 AFPE Fellows and Pharmacy Faculty Researchers.

- 30 -

AFPE Elects 2010 Officers & Members
of the Board of Directors and Board of Grants

July 12, 2010 – Rockville, MD – The Board of Directors of the American Foundation for Pharmaceutical Education (AFPE) elected the following as 2009 officers of the Board:

Chairman, Board of Directors:                       Ernest Mario, PhD
                                                                           Chairman & CEO
                                                                           Capnia, Inc.

Vice Chairman, Board of Directors:              Alice E. TIll, PhD *
                                                                          VP, Science Policy and Technical Affairs
                                                                           Pharmaceutical Research and Manufacturers of America

Treasurer, Board of Directors:                        Lonnie F. Hollingsworth, PD
                                                                           Representative
                                                                           National Community Pharmacists Association

General Counsel:                                               Joseph L. Fink, III, RPh, JD
                                                                            Professor, Social & Administrative Sciences
                                                                            College of Pharmacy
                                                                            University of Kentucky

Chairman, Board of Grants:                            Carol Ann Gloff, Ph.D.
                                                                            President
                                                                            Carol Gloff Associates

The AFPE Board of Directors elected the following individuals to the Board as new representatives of member organizations and/or sectors of the pharmaceutical business enterprise:

Chain Community Pharmacy:                          Edith A. Rosato, RPH, IOM
                                                                            Senior Vice President, Pharmacy Affairs
                                                                            National Association of Chain Drug Stores
                                                                            President
                                                                            NACDS Foundation 

Healthcare Distribution Management::          Karen J. Ribler
                                                                            Executive Vice President & COO
                                                                            Consumer Healthcare Products Association

Non Prescription Drug Manufacturing:          Wes Cetnarowski, MD
                                                                            Head, Global Research & Development
                                                                            Bayer HealthCare LLC

Pharmaceutical Research & Manufacturing:  Michael Fauerbach, MBA
                                                                             Executive Director, PharmSci Business Operations
                                                                             Pfizer Inc.                                                                          

Representing AFPE Scholars & Fellows:        William M. Heller, PhD *
                                                                            AFPE Associate Member
                                                                     

The AFPE Board of Directors elected the following individual to the AFPE Board of Grants as a representative of industry research & development:

Industry Research & Development:               Charles R. Ruffolo, Jr., PhD *
                                                                            D.Sc. (honoris causa); D.Eng. (honoris causa)
                                                                            Retired President, R&D, Wyeth Pharmaceuticals
                                                                            Retired Senior Vice President, Wyeth Corporation

* = designates person was awarded an AFPE Pre-Doctoral Fellowship in the Pharmaceutical Sciences

- 30 -

Ernest Mario Elected Chairman of AFPE Board of Directors

- Industry Leader & PhD Scientist Calls for
Increased Support of Pharmaceutical Science Education -

June 16, 2009 - Rockville, MD - The Board of Directors of the American Foundation for Pharmaceutical Education (AFPE) has elected Ernest Mario, PhD as Chairman and Chief Executive Officer (CEO) effective immediately. He assumes the chairmanship from Robert A. Ingram, Chairman Pharmaceuticals, GlaxoSmithKline, who served with distinction from 2004 – 2008.

Dr. Mario’s goal is to develop new partnerships and resources to support the education of tomorrow’s leaders in pharmaceutical science research and education. “All sectors of the pharmaceutical business enterprise can appreciate the vital role pharmaceutical scientists educated at college of pharmacy graduate programs play in advancing pharmaceutical innovations,” said Dr. Mario. “Keeping the education pipeline full of talented future pharmaceutical scientists and teachers will keep the pharmaceutical product pipeline full of important new therapies for patients worldwide.”

Dr. Mario earned his Bachelor of Science degree in pharmacy at Rutgers University and the master and doctoral degrees in physical sciences at the University of Rhode Island. A former licensed pharmacist in NY and Rhode Island, Dr. Mario began his pharmaceutical career as a research scientist with Strasenburgh Laboratories and was later recruited to positions of increased responsibility in quality control, manufacturing, new product development, and marketing at SmithKline French and E.R. Squibb. He joined Glaxo in 1986 and from 1986 – 1993, oversaw the launch of five major brands, and rose to Chief Executive and Deputy Chairman of Glaxo PLC based in London.

In 1993, Dr. Mario joined Alza Corporation in Palo Alto, CA as CEO, transforming the company into a full-fledged mid-sized pharmaceutical company that developed, manufactured, and marketed its own products until acquired by Johnson & Johnson in a 2001 merger. He served as Chairman & CEO of Reliant Pharmaceuticals, a developer and marketer of cardiovascular products until 2007 when Reliant was acquired by GlaxoSmithKline. Currently, Dr. Mario is Chairman & CEO of Capnia, a developmental-stage pharmaceutical company located in Mountain View, CA. developing a novel intranasal treatment for migraine, rhinitis, and other conditions using a proprietary medical gas delivery system. Dr. Mario has been Chairman of PPD Inc. in Wilmington, NC since 1993 and also serves on the Boards of Maxygen Inc., Celgene and Boston Scientific, as well as privately held Avid Radiopharmaceuticals.

An Eagle Scout and lifelong advocate of pharmacy education Dr. Mario is an adjunct professor of pharmacy at the University of Rhode Island and an advisor to the pharmacy schools at the University of Maryland, the University of Rhode Island, and the Ernest Mario School of Pharmacy at Rutgers University. He holds honorary doctorates from the University of Rhode Island and Rutgers University and he received pharmacy’s highest honor, the Remington Medal, from the American Pharmacists Association in 2007.

- 30 -